University Of Windsor Seeks World Stage

(WINDSOR, ON) – According to the University of Windsor, a human research centre, an alternative to animal testing, could put Canada on the world stage. Part of the work of its Canadian Centre for Alternatives to Animal Methods, launched last month, is to generate awareness of the centre’s activities.

To that end, today it will host an all-party information session at a former bank branch, now known as the John A MacDonald Building, across from Parliament Hill in Ottawa. Parliamentarians have been invited to attend to learn how the university’s new research and testing centre will be of national and international significance.

From Brazil to China, said the University, countries across the globe have established centres dedicated to alternatives to animal testing, but this is the first of its kind in Canada.

Through 21st century science, CCAAM will work at developing, validating, and promoting human-centred approaches that are faster, cheaper, and able to provide more reliable and timely science-based information. By doing this, the University said it will be able to, “advance medicine and make the best possible decisions to protect human health and the environment.”

The Canadian Centre for the Validation of Alternative Methods, an on-campus, non-animal, biomedical research and testing institute, and a CCAAM subsidiary, will be operated in close partnership with Health Canada. It will be active in various international alternatives consortia, including the Chemical Test Guidelines Program at the Organization for Economic Co-operation and Development to modernize chemical safety testing.

Up to this point, Canada has been a world leader in biomedical research but, said the University in a news release, the country does not have all the safe and effective treatments needed for testing today’s most prevalent diseases. It added that research breakthroughs often fail to make it into the nation’s clinics because of the difficulty of accurately translating discoveries from lab animals to human patients, mostly a result of immutable biological differences.

CCAAM and CaCVAM officially launched on October 2 with three major initiatives: research, academic, and regulatory testing and policy, establishing human-centred health research and chemical safety testing.

Click for the latest news

About the Author

Ian Shalapata

Ian Shalapata is the owner and publisher of Square Media Group. He covers politics, the police beat, community events, the arts, sports, and everything in between.

His imagery and freelance contributions have appeared in select publications and for organizations in Canada and the United States.

Contact Ian with story ideas.